BE839744A - Composes a effet anti-depressif et procedes de preparation - Google Patents

Composes a effet anti-depressif et procedes de preparation

Info

Publication number
BE839744A
BE839744A BE165316A BE165316A BE839744A BE 839744 A BE839744 A BE 839744A BE 165316 A BE165316 A BE 165316A BE 165316 A BE165316 A BE 165316A BE 839744 A BE839744 A BE 839744A
Authority
BE
Belgium
Prior art keywords
compounds
preparation
methods
depressive effect
depressive
Prior art date
Application number
BE165316A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE839744A publication Critical patent/BE839744A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE165316A 1975-03-20 1976-03-18 Composes a effet anti-depressif et procedes de preparation BE839744A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
BE839744A true BE839744A (fr) 1976-09-20

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
BE165316A BE839744A (fr) 1975-03-20 1976-03-18 Composes a effet anti-depressif et procedes de preparation

Country Status (27)

Country Link
US (1) US4085225A (cs)
JP (1) JPS6026776B2 (cs)
AR (2) AR211011A1 (cs)
AT (1) AT340895B (cs)
AU (1) AU505358B2 (cs)
BE (1) BE839744A (cs)
CA (1) CA1076142A (cs)
CH (4) CH626057A5 (cs)
DD (1) DD128332A5 (cs)
DE (1) DE2610886A1 (cs)
DK (1) DK144942C (cs)
ES (1) ES446192A1 (cs)
FI (1) FI61875C (cs)
FR (1) FR2304336A1 (cs)
GB (1) GB1535226A (cs)
GR (1) GR60052B (cs)
HU (1) HU171030B (cs)
IE (1) IE43768B1 (cs)
IL (1) IL49238A (cs)
IT (1) IT1063064B (cs)
MX (1) MX9203723A (cs)
NL (1) NL7503310A (cs)
PL (3) PL100052B1 (cs)
SE (1) SE410312B (cs)
SU (3) SU635867A3 (cs)
YU (1) YU39345B (cs)
ZA (1) ZA761434B (cs)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
ES2145977T3 (es) * 1995-08-16 2000-07-16 Lilly Co Eli Potenciacion de la respuesta de la serotonina.
IN182588B (cs) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (cs) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
EP1276478A2 (en) * 2000-04-24 2003-01-22 ARYx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
ES2666188T3 (es) * 2001-10-12 2018-05-03 Azevan Pharmaceuticals, Inc. Antagonistas del v1a de vasopresina beta-lactámicos
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
EP1651195A4 (en) * 2003-07-11 2007-10-03 Myriad Genetics Inc PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
CA2537402C (en) 2003-09-12 2009-05-05 Pfizer Inc. Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
DE602004028150D1 (de) * 2003-11-26 2010-08-26 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006227199A1 (en) 2005-03-22 2006-09-28 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
AU2006239897A1 (en) * 2005-04-22 2006-11-02 Wyeth Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
CN101203216A (zh) * 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
CA2605554A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
CN101175740A (zh) 2005-04-22 2008-05-07 惠氏公司 二氢苯并呋喃衍生物和其用途
NZ565683A (en) * 2005-07-08 2011-04-29 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis in human neural cells
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
RU2466991C2 (ru) * 2005-07-19 2012-11-20 Эйзеван Фармасьютиклз, Инк. β-ЛАКТАМИЛЗАМЕЩЕННЫЕ АНАЛОГИ ФЕНИЛАЛАНИНА, ЦИСТЕИНА И СЕРИНА В КАЧЕСТВЕ АНТАГОНИСТОВ ВАЗОПРЕССИНА
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
PA8720801A1 (es) * 2006-03-24 2008-11-19 Wyeth Corp Nuevas combinaciones terapeuticas para el tratamiento de la depresion
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
KR101859409B1 (ko) 2009-10-23 2018-05-18 얀센 파마슈티카 엔.브이. 오렉신 수용체 조절제로서의 이치환된 옥타하이드로피롤로［3,4-ｃ］피롤
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
ES2858499T3 (es) 2010-07-01 2021-09-30 Azevan Pharmaceuticals Inc Compuestos para su uso en el tratamiento de trastorno explosivo intermitente
BR112013023810A2 (pt) 2011-03-17 2016-12-13 Lupin Ltd composições farmacêuticas de liberação controlada de inibidores seletivos da recaptação de serotonina
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
IN2013MU01290A (cs) 2013-04-03 2015-04-10 Zcl Chemicals Ltd
WO2015118365A1 (en) 2014-02-07 2015-08-13 Mta Támogatott Kutatócsoportok Irodája Novel use of sigma-1 receptor agonist compounds
SG10202001065SA (en) 2014-03-28 2020-04-29 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases
SG11201807597UA (en) 2016-03-10 2018-10-30 Janssen Pharmaceutica Nv Methods of treating depression using orexin-2 receptor antagonists
CN110337244B (zh) 2016-11-24 2023-07-21 西格玛研究有限责任公司 用于器官保藏的组合物
CA3075759A1 (en) 2017-09-15 2019-03-21 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury
JP7739256B2 (ja) 2019-07-19 2025-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
YU71476A (en) 1982-10-31
GR60052B (en) 1978-04-04
JPS51125345A (en) 1976-11-01
DE2610886C2 (cs) 1987-09-24
CH629477A5 (de) 1982-04-30
IE43768B1 (en) 1981-05-20
DE2610886A1 (de) 1976-10-07
SE410312B (sv) 1979-10-08
FI61875C (fi) 1982-10-11
AU505358B2 (en) 1979-11-15
MX9203723A (es) 1992-07-01
CH629184A5 (de) 1982-04-15
CA1076142A (en) 1980-04-22
SU645559A3 (ru) 1979-01-30
PL101951B1 (pl) 1979-02-28
SU635867A3 (ru) 1978-11-30
IL49238A0 (en) 1976-05-31
FI760699A7 (cs) 1976-09-21
DK144942C (da) 1982-12-06
PL100052B1 (pl) 1978-08-31
DD128332A5 (de) 1977-11-09
GB1535226A (en) 1978-12-13
IL49238A (en) 1978-08-31
DK144942B (da) 1982-07-12
JPS6026776B2 (ja) 1985-06-25
CH629761A5 (de) 1982-05-14
NL7503310A (nl) 1976-09-22
SE7603341L (sv) 1976-09-21
HU171030B (hu) 1977-10-28
AU1214776A (en) 1977-09-22
PL100614B1 (pl) 1978-10-31
SU620206A3 (ru) 1978-08-15
AR211011A1 (es) 1977-10-14
DK115976A (da) 1976-09-21
AR211153A1 (es) 1977-10-31
FR2304336B1 (cs) 1979-09-28
FI61875B (fi) 1982-06-30
ATA195476A (de) 1977-05-15
IE43768L (en) 1976-09-20
ZA761434B (en) 1977-10-26
ES446192A1 (es) 1977-10-01
US4085225A (en) 1978-04-18
CH626057A5 (cs) 1981-10-30
AT340895B (de) 1978-01-10
FR2304336A1 (fr) 1976-10-15
YU39345B (en) 1984-10-31
IT1063064B (it) 1985-02-11

Similar Documents

Publication Publication Date Title
FR2304336A1 (fr) Composes a effet anti-depressif et procedes de preparation
FR2316201A1 (fr) Similigranite et sa preparation
FR2338251A1 (fr) Nouveau compose peptidique et sa preparation
FR2296654A1 (fr) Polycarbonates thermoplastiques ramifies et leur preparation
MX143009A (es) Cateter mejorado
FR2333519A1 (fr) Catheter uretral
BE857558A (fr) Amelioration des catheters
SE7700032L (sv) Framstellning av n-fosfonometylglysin
FR2313685A1 (fr) Hydrophone perfectionne insensible aux accelerations
SE433092B (sv) Forfarande for forvermning och patentering samt streckning av en staltrad
NO143350C (no) 3-oximer av d-17alfa-etynyl-19-nortestosteronestere med befruktningshindrende virkning
BE853418A (fr) Articles a fumer et procede de preparation
SE7606366L (sv) Kateter
FR2345439A1 (fr) Dihydrooxadiazinones et leurs procedes de preparation
AU499080B2 (en) Ortho-aminobutyrophenone derivatives and salts thereof
BE840866A (fr) Composition therapeutique a activite anti-agregante plaquettaire
IT1061236B (it) Volcanizzati sigillabili a caldo e procedimento per produrli
FR2318863A1 (fr) Bestatine et ses derives
FR2301511A1 (fr) Pentafluorsethylarylamines et leurs procedes de preparation
SE7604448L (sv) Diastereoisomerer av fenylaminoetanol-derivat
DK122576A (da) Signalspidsverdidetektor
BE861351A (fr) Composes alcanoylanilides et leur preparation
SE427272B (sv) Framstellning av nikotinamid
AU510882B2 (en) Esters of naphthyl allohols
FR2304335A1 (fr) Composes a effet anti-depressif

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0058

CCPV Grant of a supplementary protection certificate

Free format text: 093C0058, EXPIRES 19990103

RE20 Patent expired

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V.

Effective date: 19960318